Comparative study on contact diode laser transscleral cyclophotocoagulation and Ahmed glaucoma valve in the management of neovascular glaucoma.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000646

Enrollment

Unknown

Registered

2005-09-08

Start date

2003-08-05

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Two groups:Cyclophotocoagulation with G-probe 20 minutes versus Ahmed Glaucoma Drainage Device

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criteria New vessels on iris and/or anterior chamber angle due to an ischemic etiology IOP > 21mmHg despite maximally tolerated medical treatment

Exclusion criteria

Exclusion criteria: Exclusion criteria Eyes with no light perception New vessels on iris and/or anterior chamber angle due to neoplastic etiology History of previous glaucoma surgery or cyclodestruction

Design outcomes

Primary

Measure	Time frame
IOP;	—

Secondary

Measure	Time frame
Number of antiglaucoma medications Best corrected visual acuity (BCVA) Optic nerve head morphology - qualitative and quantitative (OCT III) Complications;	—

Countries

China

Contacts

Public ContactProf. Clement CY Tham

www.na@163.com+852 2762 3196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026